Michael F Giordano
CIK 1733915 · last filed 2026-03-05
Michael F Giordano is a corporate insider who has filed 17 SEC Form 4 insider transactions across 2 companies since 2018. Across all open-market trades the lifetime net is −$634.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
17
-$634.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 4,956 | $58.01 | $287.5K | -$634.5K | 10 | 2026-02-02 |
| Epizyme, Inc. (EPZM) Delisted | Director | 17,054 | $1.47 | $25.1K | $0 | 5 | 2022-05-19 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-05 | — | Mixed | −4,956 | $0 | |
| 2026-02-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | +4,956 | $0 | EDGAR |
| 2025-06-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-16 | — | Disp (D) | −17,054 | $0 | |
| 2022-05-26 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +8,994 | $0 | EDGAR |
| 2022-04-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-24 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |